| Ticker | ALVR |
|---|---|
| ISIN | US4829291065 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical development product candidates include ALVR106 for the...
El precio actual de AlloVir, Inc. (ALVR) es de 9,81 , con una variación del 4,14%.
AlloVir, Inc. opera en el sector Healthcare, industria Biotechnology.